Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elzbieta Muszynska

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Lancet. Psychiatry|October 3, 2018
The growing problem of mephedrone use in Warsaw, Poland, 2010-18Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska
International Journal of Psychiatry in Clinical Practice|October 31, 2019
Optimisation of methadone treatment in a group of patients on a mephedrone binge and dependent on many psychoactive substancesMichal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, et al.
Journal of Clinical Medicine|August 7, 2021
Psychoactive Substances Taken with Mephedrone and HCV InfectionMichal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, et al.
Journal of Clinical Medicine|June 2, 2021
Increasing the Effectiveness of Pharmacotherapy in Psychiatry by Using a Pharmacological Interaction DatabaseMichal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, et al.
Substance Use & Misuse|April 21, 2020
The Psychiatric Characteristics of People on a Mephedrone ("bath salts") BingeMichal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, et al.
International Journal of Psychiatry in Clinical Practice|June 4, 2020
Effectiveness of the methadone programme in the treatment of patients on a mephedrone binge and dependent on heroin: a retrospective study, 2010-19Michal Ordak, Tadeusz Nasierowski, Karolina Pawlik, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 15, 2021
Manganese concentration in patients with encephalopathy following ephedrone use: a narrative review and analysis of case reportsMichal Ordak, Natalia Sloniewicz, Tadeusz Nasierowski, et al.
Pharmacological Reports : PR|June 27, 2017
Magnesium in schizophreniaMichal Ordak, Joanna Matras, Elzbieta Muszynska, et al.
Toxics|April 28, 2023
Reasons, Form of Ingestion and Side Effects Associated with Consumption of <i>Amanita muscaria</i>Michal Ordak, Aleksandra Galazka, Tadeusz Nasierowski, et al.
General Hospital Psychiatry|November 21, 2017
Level of magnesium in psychiatry - What is the cause of ambiguous results?Michal Ordak, Elzbieta Muszynska, Tadeusz Nasierowski, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Lancet. Psychiatry|October 3, 2018
The growing problem of mephedrone use in Warsaw, Poland, 2010-18Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska
International Journal of Psychiatry in Clinical Practice|October 31, 2019
Optimisation of methadone treatment in a group of patients on a mephedrone binge and dependent on many psychoactive substancesMichal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, et al.
Journal of Clinical Medicine|August 7, 2021
Psychoactive Substances Taken with Mephedrone and HCV InfectionMichal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, et al.
Journal of Clinical Medicine|June 2, 2021
Increasing the Effectiveness of Pharmacotherapy in Psychiatry by Using a Pharmacological Interaction DatabaseMichal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, et al.
Substance Use & Misuse|April 21, 2020
The Psychiatric Characteristics of People on a Mephedrone ("bath salts") BingeMichal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, et al.
International Journal of Psychiatry in Clinical Practice|June 4, 2020
Effectiveness of the methadone programme in the treatment of patients on a mephedrone binge and dependent on heroin: a retrospective study, 2010-19Michal Ordak, Tadeusz Nasierowski, Karolina Pawlik, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 15, 2021
Manganese concentration in patients with encephalopathy following ephedrone use: a narrative review and analysis of case reportsMichal Ordak, Natalia Sloniewicz, Tadeusz Nasierowski, et al.
Pharmacological Reports : PR|June 27, 2017
Magnesium in schizophreniaMichal Ordak, Joanna Matras, Elzbieta Muszynska, et al.
Toxics|April 28, 2023
Reasons, Form of Ingestion and Side Effects Associated with Consumption of <i>Amanita muscaria</i>Michal Ordak, Aleksandra Galazka, Tadeusz Nasierowski, et al.
General Hospital Psychiatry|November 21, 2017
Level of magnesium in psychiatry - What is the cause of ambiguous results?Michal Ordak, Elzbieta Muszynska, Tadeusz Nasierowski, et al.
Pageof 2